Abstract
This chapter describes a review of proton therapy (PT) centers and the techniques used for the treatment of ocular lesions. The role of ion beam therapy (IBT) for eye treatments, principally choroidal melanomas, has become well established among the competing treatment modalities. More national centers now offer PT for these lesions, but not necessarily in a hospital environment. Significant improvements in eye treatment planning, patient positioning, and QA dosimetry have been realized, to the benefit of treatment efficiency and accuracy of dose delivery.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
A. Kacperek, Ophthalmological Proton Facilities, in Ion Beams in Tumor Therapy, ed. by U. Linz. (Chapman & Hall, London, 1995), pp. 360–370
M. Jermann, Particles Newsletter of the Particle Therapy Co-Operative Group (PTCOG). Available at http://ptcog.web.psi.ch/. Accessed 5 Sep 2011
J. Castro, D. Char, P. Petti, et al, 15 years experience with helium ion radiotherapy for uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 39, 989–996 (1997)
H. Koyama-Ito, T. Kanai, S. Minohara, et al., Carbon ion therapy for ocular melanoma: planning orthogonal two-port treatment. Phys. Med. Biol. 52, 5341–5352 (2007)
E.S. Gragoudas, M. Goitein, A.M. Koehler, et al., Proton irradiation of small choroidal malignant melanomas. Am. J. Ophthalmol. 83, 655–673 (1977)
M. Goitein, T. Miller, Planning proton therapy of the eye. Med. Phys. 10, 275–283 (1983)
K.K. Mishra, J.M. Quivey, I.K. Daftari, D.H. Char, Uveal Melanoma, in Leibel and Phillips Textbook of Radiation Oncology, ed. by R. Hoppe, T. Phillips, M. Roach. 3rd edn. (Saunders, Philadelphia, 2010), pp. 1400–1421
B. Damato, A. Kacperek, M. Chopra, et al., Proton beam radiotherapy of iris melanoma. Int. J. Radiat. Oncol. Biol. Phys. 63, 109–115 (2005)
H. Wuestemeyer, W. Sauerwein, D. Meller, et al., Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefe’s Arch. Clin. Exp. Ophthalmol. 244, 438–446 (2006)
A. Zytkovicz, I. Daftari, T.L. Philips, et al., Peripheral dose in ocular treatments with CyberKnife and gamma knife radiosurgery compared to proton radiotherapy. Phys. Med. Biol. 52, 5957–5971 (2007)
D. Weber, J. Bogner, J. Verwey, et al., Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: a comparative study. Int. J. Radiat. Oncol. Biol. Phys. 63, 373–384 (2005)
E.S. Gragoudas, Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. Invest. Ophthalmol. Vis. Sci. 47, 4666–4673 (2006)
R. Dendale, L. Lumbroso-Le Rouic, G. Noel, et al., Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int. J. Radiat. Oncol. Biol. Phys. 65, 780–787 (2006)
J.E. Munzenrider, Proton therapy for uveal melanomas and other eye lesions. Strahlenther Onkol. 175, S68–S73 (1999)
E. Egger, L. Zografos, A. Schalenbourg, et al., Eye retention after proton beam radiotherapy for uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 55, 867–880 (2003)
B. Damato, A. Kacperek, M. Chopra, et al., Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int. J. Radiat. Oncol. Biol. Phys. 62, 1405–1411 (2005)
A.J.E. Foss, I. Whelehan, J.L. Hungerford, et al., Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br. J. Ophthalmol. 81, 748–754 (1997)
J. Flanz, A. Smith, Technology for proton therapy. Cancer J. 15, 292–297 (2009)
International Commission on Radiation Units and Measurements. Clinical Proton Dosimetry Part I: Beam Production, Beam Delivery and Measurement of Absorbed Dose. ICRU Report 59 (Bethesda, MD USA, 1998)
B. Andreo, D.T. Burns, K. Hohlfeld, et al., IAEA TRS-398 Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry Based on Standards of Absorbed Dose to Water (IAEA, Vienna, 2000), pp. 35–50
M. Goitein, R. Gentry, A.M. Koehler, Energy of proton accelerator necessary for treatment of choroidal melanomas. Int. J. Radiat. Oncol. Biol. Phys. 9, 259–260 (1983)
B. Gottschalk, Proton Nozzle Design Program NEU. Harvard Cyclotron Laboratory, Internal Report, HCL 3/32/90 (1990)
A.M. Koehler, R.J. Schneider, J.M. Sisterson, Range modulators for protons and heavy ions. Nucl. Instrum. Methods Phys. Res. 131, 437–440 (1975)
D.E. Bonnett, A. Kacperek, M.A. Sheen, et al., The 62 MeV proton beam for the treatment of ocular melanoma at Clatterbridge. Br. J. Radiol. 66, 907–914 (1993)
P. van Luijk, A.A. van t’ Veld, H.D. Zelle, et al., Collimator scatter and 2D dosimetry in small proton beams. Phys. Med. Biol. 46, 653–670 (2001)
A. Kacperek, Protontherapy of eye tumours in the UK: A review of treatment at Clatterbridge. Appl. Radiat. Isot. 67, 378–386 (2009)
Altomed Limited, Boldon, UK, Ta fiduciary markers (CE marked), http://www.altomed.com/contacts/index.html
J. Heufelder, R. Stark, A. Weber, Influence of tantalum marker clips used in eye tumour therapy on the dose distribution of a 68 MeV proton beam. Biomed. Technik. 50(Suppl 1), 344–345 (2005)
I.K. Daftari, T. Essert, T.L. Phillips, Application of flat panel digital imaging for improvement of ocular melanoma patient set-up in proton beam therapy. Nucl. Instrum. Methods Phys. Res. A 598, 628–634 (2009)
J. Bogner, B. Petersch, D. Georg, et al., A non-invasive eye fixation and computer-aided eye monitoring system for linear accelerator–based stereotactic radiotherapy of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 56, 1128–1136 (2003)
S. Agosteo, C. Birattari, M. Caravaggio, et al., Secondary neutron and photon dose in proton therapy. Radiother. Oncol. 48, 293–305 (1998)
F. Trompier, S. Delacroix, I. Vabre, et al., Secondary exposure for 73 and 200 MeV proton therapy. Radiat. Prot. Dosim. 125, 349–354 (2007)
A. Cesana, E. Mauro, M. Silari, Induced radioactivity in a patient-specific collimator used in proton therapy. Nucl. Instrum. Methods Phys. Res. B, 268, 2272–2280 (2010)
A. Kacperek, Dose verification by activation in vivo following proton beam eye radiotherapy. J. Radioanal. Nucl. Chem. 271, 731–740 (2007)
E.S. Gragoudas, M. Goitein, A.M. Koehler, et al., Proton irradiation of small choroidal malignant melanomas. Am. J. Ophthalmol. 83, 655–673 (1977)
E.S. Gragoudas, A.M. Lane, S. Regan, et al., A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch. Ophthalmol. 118, 773–778 (2000)
G. Wollensak, L. Zografos, C. Perret, et al., Experimental study on the fractionation schedule for proton irradiation of uveal melanoma. Graef. Arch. Clin. Exp. 228, 562–568 (1990)
H. Paganetti, M. Goitein, Radiobiological significance of beamline dependent proton energy distributions in a spread-out Bragg peak. Med. Phys. 27, 1119–1126 (2000)
H. Paganetti, Calculation of the spatial variation of relative biological effectiveness in a therapeutic proton field for eye treatment. Phys. Med. Biol. 43, 2147–2157 (1998)
C. Perret, R. Greiner, L. Zografos, C. Gailloud, Die Behandlung intraokularer Melanome mit Protonen am Paul Scherrer Institut (PSI). Juli 1988. ID PSI/2000
E. Egger, A. Schalenbourg, L. Zografos, et al., Maximising local tumour control and survival after proton beam radiotherapy of uveal melanoma. Int. J. Radiat. Oncol. Biol. Phys. 51, 138–147 (2001)
J. Heufelder, D. Cordini, H. Fuchs, et al., Five years of proton therapy of eye neoplasms at the Hahn-Meitner Institute, Berlin. Z. Med. Phys. 14, 64–71 (2004)
I.K. Daftari, K.K. Mishra, J.M. O’Brien, et al., Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning. Med. Phys. 37, 5199–5207 (2010)
B. Dobler, R. Bendl, Precise modelling of the eye for proton therapy of intra-ocular tumours Phys. Med. Biol. 47, 593–613 (2002)
C. Rethfeldt, H. Fuchs, K.U. Gardey, Dose distributions of a proton beam for eye tumor therapy: hybrid pencil-beam ray-tracing calculations. Med. Phys. 33, 782–791 (2006)
J. Herault, N. Iborra, B. Serrano, et al., Spread-out Bragg peak and monitor units calculation with the Monte Carlo Code MCNPX. Med. Phys. 34, 680–688 (2007)
H.M. Kooy, M. Schaefer, S. Rosenthal, et al., Monitor unit calculations for range-modulated spread-out Bragg peak fields. Phys. Med. Biol. 48, 2797–2808 (2003)
H. Palmans, R. Thomas, M. Simon, et al., A small-body portable graphite calorimeter for dosimetry in low-energy clinical proton beams. Phys. Med. Biol. 49, 3737–3749 (2004)
S. Vynckier, D.E. Bonnett, D.T.L. Jones, Code of practice for clinical proton dosimetry (ECHED). Radiother. Oncol. 20, 53–63 (1991); Suppl. Radiother. Oncol. 32, 174–179 (1994)
N. Koch, W. Newhauser, Virtual commissioning of a treatment planning system for proton therapy of ocular cancers. Radiat. Prot. Dosim. 115, 159–163 (2004)
C. Baker, D. Shipley, H. Palmans, et al., Monte carlo modelling of a clinical proton beam-line for the treatment of ocular tumours. Nucl. Instrum. Methods Phys. Res. A 562, 1005–1008 (2006)
J. Heufelder, S. Stiefel, M. Pfaender, et al., Use of BANG polymer gel for dose measurements in a 68 MeV proton beam. Med. Phys. 30, 1235–1240 (2003)
L. Czopyk, G.A.P. Cirrone, G. Cuttone, et al., 2D dosimetry of a proton radiotherapy beam using large-area LiF: Mg, Cu, P TL detectors. Radiat. Meas. 43, 977–980 (2008)
S. Al-Nowais, S. Doran, A. Kacperek, et al., A preliminary analysis of LET effects in the dosimetry of proton beams using PRESAGETM and optical CT. Appl. Radiat. Isot. 67, 415–418 (2009)
A.B. Rosenfeld, D. Cutajar, M.L. Lerch, et al., Miniature semiconductor detectors for in vivo dosimetry. Radiat. Prot. Dosim. 120, 48–55 (2006)
D.H. Char, R. Bove, T.L. Phillips, Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments. Am. J. Ophthalmol. 136, 180–182 (2003)
H.J. Zambarakji, A.M. Lane, E. Ezra, et al., Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology 113, 2012–2019 (2006)
Acknowledgements
I am indebted to my colleagues from the following proton eye therapy centers: Jorn Verwey (PSI, Villigen), Sabine Delacroix (CPO, Paris), Ewan Blackmore (TRIUMF, Vancouver), Jens Heufelder (HZB-Charité, Berlin), Jan Swakon (IFJ, Kraków), Joel Hérault (CAL, Nice), Pablo Cirrone (INFN-LNS, Catania), Inder Daftari (UCSF, San Francisco), and Hanne Kooy (MGH, Boston).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kacperek, A. (2012). Ocular Proton Therapy Centers. In: Linz, U. (eds) Ion Beam Therapy. Biological and Medical Physics, Biomedical Engineering, vol 320. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21414-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-21414-1_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-21413-4
Online ISBN: 978-3-642-21414-1
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)